• RESOURCES
  • Products
    products details
    Home > Products >
    Teriparatide acetate Catalog Number KS062003 CAS NO. 52232-67-4

    Teriparatide acetate Catalog Number KS062003 CAS NO. 52232-67-4

    Product Details:
    Catalog Number:
    KS062003
    Product Name:
    Teriparatide Acetate
    Sequence:
    SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF-OH
    CAS NO.:
    52232-67-4
    Price/1mg:
    $280
    Purity:
    ≥95% (HPLC)
    Molecular Formula:
    C181H291N55O51S2
    Molecular Weight:
    4117.77
    Form:
    Lyophilized
    Storage:
    Store At -20°C Or -80°C
    Product Description

    Teriparatide acetate is a synthetic form of parthyroid hormone (PTH). PTH regulates the metabolism of calcium and phosphate. PTH and PTH-related polypeptide (PTHrP) play important roles in calcium homeostasis of bone, kidney, breast, and placenta; they signal via the PTH/PTHrP and PTH2 receptors. PTH(1–34) administration suppresses cardiovascular calcification and down-regulates aortic osteogenic programs driven by diabetes and dyslipidemia.

    Products
    products details
    Home > Products >
    Teriparatide acetate Catalog Number KS062003 CAS NO. 52232-67-4

    Teriparatide acetate Catalog Number KS062003 CAS NO. 52232-67-4

    Product Details:
    Catalog Number:
    KS062003
    Product Name:
    Teriparatide Acetate
    Sequence:
    SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF-OH
    CAS NO.:
    52232-67-4
    Price/1mg:
    $280
    Purity:
    ≥95% (HPLC)
    Molecular Formula:
    C181H291N55O51S2
    Molecular Weight:
    4117.77
    Form:
    Lyophilized
    Storage:
    Store At -20°C Or -80°C
    Details Link:
    Https://shopping.ks-vpeptide.com/sale-470471-teriparatide-acetate-catalog-number-ks062003-cas-no-52232-67-4.htm
    Product Description

    Teriparatide acetate is a synthetic form of parthyroid hormone (PTH). PTH regulates the metabolism of calcium and phosphate. PTH and PTH-related polypeptide (PTHrP) play important roles in calcium homeostasis of bone, kidney, breast, and placenta; they signal via the PTH/PTHrP and PTH2 receptors. PTH(1–34) administration suppresses cardiovascular calcification and down-regulates aortic osteogenic programs driven by diabetes and dyslipidemia.